Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.453NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.350NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.315NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.162NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.424NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.264NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.581NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.330NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.177NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.301NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.308NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.210NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.590NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.496NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.438.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.49 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.497NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.30 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.85 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.571NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.55 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.239NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.574NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used